Healthpeak Properties, Inc. (NYSE:DOC) Position Raised by Commerzbank Aktiengesellschaft FI

Commerzbank Aktiengesellschaft FI increased its position in shares of Healthpeak Properties, Inc. (NYSE:DOC) by 3.9% during the 4th quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 21,002 shares of the real estate investment trust’s stock after purchasing an additional 797 shares during the period. Commerzbank Aktiengesellschaft FI’s holdings in Healthpeak Properties were worth $420,000 at the end of the most recent quarter.

Other institutional investors also recently modified their holdings of the company. JPMorgan Chase & Co. increased its holdings in shares of Healthpeak Properties by 23.2% in the third quarter. JPMorgan Chase & Co. now owns 21,561,640 shares of the real estate investment trust’s stock valued at $493,115,000 after buying an additional 4,056,931 shares in the last quarter. Thrivent Financial for Lutherans bought a new position in shares of Healthpeak Properties in the third quarter valued at $1,880,000. Swedbank AB bought a new position in shares of Healthpeak Properties in the third quarter valued at $1,832,000. Pathstone Holdings LLC bought a new position in shares of Healthpeak Properties in the third quarter valued at $1,968,000. Finally, Associated Banc Corp bought a new position in shares of Healthpeak Properties in the third quarter valued at $10,559,000. Institutional investors own 93.57% of the company’s stock.

Healthpeak Properties Trading Up 1.0 %

Healthpeak Properties stock opened at $20.45 on Thursday. The company’s fifty day simple moving average is $20.19 and its 200-day simple moving average is $21.32. The company has a quick ratio of 1.35, a current ratio of 1.35 and a debt-to-equity ratio of 0.96. Healthpeak Properties, Inc. has a 12 month low of $16.66 and a 12 month high of $23.26. The stock has a market cap of $14.30 billion, a P/E ratio of 58.42, a P/E/G ratio of 2.17 and a beta of 1.15.

Healthpeak Properties Increases Dividend

The business also recently declared a quarterly dividend, which was paid on Wednesday, February 26th. Stockholders of record on Friday, February 14th were issued a dividend of $0.305 per share. This is a boost from Healthpeak Properties’s previous quarterly dividend of $0.30. This represents a $1.22 annualized dividend and a dividend yield of 5.97%. The ex-dividend date of this dividend was Friday, February 14th. Healthpeak Properties’s payout ratio is currently 348.57%.

Analysts Set New Price Targets

DOC has been the topic of several research reports. Wedbush dropped their price target on Healthpeak Properties from $27.00 to $24.00 and set an “outperform” rating on the stock in a report on Friday, February 14th. Scotiabank lowered their price objective on shares of Healthpeak Properties from $24.00 to $23.00 and set a “sector outperform” rating on the stock in a research report on Friday, February 28th. Mizuho lowered their price objective on shares of Healthpeak Properties from $25.00 to $24.00 and set an “outperform” rating on the stock in a research report on Thursday, December 5th. Morgan Stanley upgraded shares of Healthpeak Properties from an “equal weight” rating to an “overweight” rating and set a $25.00 price objective on the stock in a research report on Wednesday, January 15th. Finally, Robert W. Baird lowered their price objective on shares of Healthpeak Properties from $25.00 to $24.00 and set an “outperform” rating on the stock in a research report on Tuesday, February 11th. One analyst has rated the stock with a sell rating, three have assigned a hold rating, ten have assigned a buy rating and one has issued a strong buy rating to the company. Based on data from MarketBeat.com, Healthpeak Properties currently has a consensus rating of “Moderate Buy” and an average target price of $23.92.

Healthpeak Properties Company Profile

Healthpeak Properties, Inc is a fully integrated real estate investment trust (REIT) and S&P 500 company. Healthpeak owns, operates, and develops high-quality real estate for healthcare discovery and delivery.